We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$53.6B
AUM Growth
+$2.66B
(+5.2%)
Cap. Flow
+$86.8M
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
37.17%
Holding
821
New
56
Increased
227
Reduced
258
Closed
253
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$86.2M |
| 2 |
Alcon
ALC
|
+$81.8M |
| 3 |
NVIDIA
NVDA
|
+$76M |
| 4 |
Corning
GLW
|
+$50.4M |
| 5 |
UnitedHealth
UNH
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$67.4M |
| 2 |
Factset
FDS
|
+$62M |
| 3 |
Euronet Worldwide
EEFT
|
+$42.3M |
| 4 |
Bank of America Series L
BAC.PRL
|
+$39.5M |
| 5 |
OPLN
Openlane
OPLN
|
+$31.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 17.74% |
| 3 | Financials | 11.65% |
| 4 | Healthcare | 11.2% |
| 5 | Communication Services | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRSU
176
Pursuit Attractions and Hospitality Inc
PRSU
$1.3B
| $22.8M | 0.04% |
344,085
-17,704
| -5% | -$1.09M |
|
|
HMSY
177
DELISTED
HMS Holdings Corp.
HMSY
| $22.7M | 0.04% |
700,845
+116,687
| +20% | +$3.57M |
|
|
SBNY
178
DELISTED
Signature Bank
SBNY
| $22.7M | 0.04% |
187,668
-8,680
| -4% | -$1.07M |
|
|
BEAT
179
DELISTED
BioTelemetry, Inc.
BEAT
| $22.5M | 0.04% |
466,793
+22,858
| +5% | +$1.2M |
|
|
EFOR
180
Everforth Inc
EFOR
$1.29B
| $22.1M | 0.04% |
364,651
+159,561
| +78% | +$9.58M |
|
181
Evertec
EVTC
$1.85B
| $21.9M | 0.04% |
671,065
+22,234
| +3% | +$654K |
|
|
BAND
182
Bandwidth Inc
BAND
$1.44B
| $21.6M | 0.04% |
288,033
+91,787
| +47% | +$6.7M |
|
183
Essent Group
ESNT
$6.04B
| $21.5M | 0.04% |
457,295
+124,011
| +37% | +$5.84M |
|
|
XIFR
184
XPLR Infrastructure LP
XIFR
$1.08B
| $21.3M | 0.04% |
442,301
-3,917
| -0.9% | -$182K |
|
185
Ambev
ABEV
$46.5B
| $21.3M | 0.04% |
4,558,261
+1,335,667
| +41% | +$5.98M |
|
186
Astronics
ATRO
$3.75B
| $21.3M | 0.04% |
634,607
+31,074
| +5% | +$977K |
|
187
AAR Corp
AIR
$5.89B
| $21.2M | 0.04% |
576,800
+28,243
| +5% | +$934K |
|
188
Xencor
XNCR
$1.49B
| $21.2M | 0.04% |
518,135
+95,810
| +23% | +$3.15M |
|
|
OPLN
189
Openlane
OPLN
$4.62B
| $20.4M | 0.04% |
817,528
-1,454,859
| -64% | -$31.3M |
|
190
EPAM Systems
EPAM
$4.86B
| $20.4M | 0.04% |
117,578
-7,091
| -6% | -$1.22M |
|
|
CSOD
191
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $20.3M | 0.04% |
350,094
+17,142
| +5% | +$928K |
|
|
AGS
192
DELISTED
PlayAGS
AGS
| $20.1M | 0.04% |
1,031,656
+32,437
| +3% | +$698K |
|
|
WCG
193
DELISTED
Wellcare Health Plans, Inc.
WCG
| $19.9M | 0.04% |
69,794
-24,423
| -26% | -$6.73M |
|
194
Primoris Services
PRIM
$4.32B
| $19.6M | 0.04% |
936,859
+37,408
| +4% | +$767K |
|
195
Teleflex
TFX
$6.15B
| $19.4M | 0.04% |
58,585
-2,977
| -5% | -$899K |
|
196
James River Group Holdings
JRVR
$221M
| $19.1M | 0.04% |
+407,701
| New | +$17.7M |
|
197
American Water Works
AWK
$26.8B
| $18.9M | 0.04% |
162,833
-8,611
| -5% | -$950K |
|
198
Sun Communities
SUI
$14.7B
| $18.7M | 0.03% |
145,998
-22,874
| -14% | -$2.84M |
|
|
RETA
199
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $18.5M | 0.03% |
+196,589
| New | +$17M |
|
|
ATSG
200
DELISTED
Air Transport Services Group
ATSG
| $18.3M | 0.03% |
748,276
+36,694
| +5% | +$843K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2019 Portfolio in Review
As of Q2 2019, Loomis, Sayles & Company held 821 positions worth $53.6B, up 5.2% from $50.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Loomis, Sayles & Company's Q2 2019 filing shows 56 new, 227 increased, 258 reduced and 253 closed positions. Its largest new stake was Alcon: 1,393,674 shares worth $86.5M. The largest sale was Novartis, an estimated $67.4M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q2 2019 buy was Alcon: 1,393,674 shares worth $86.5M.
- Loomis, Sayles & Company added most to Bristol-Myers Squibb in Q2 2019, an estimated $86.2M increase.
- Loomis, Sayles & Company's biggest Q2 2019 reduction was Novartis, cutting an estimated $67.4M.
- Loomis, Sayles & Company fully exited RingCentral in Q2 2019, selling an estimated $30.4M.
- Loomis, Sayles & Company's ten largest holdings make up 37% of its $53.6B portfolio in Q2 2019.
- Loomis, Sayles & Company opened 56 new positions and closed 253 in Q2 2019.
- Loomis, Sayles & Company's portfolio value rose 5.2% quarter-over-quarter to $53.6B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2019, filed 14 Aug 2019.